sees fy sales $4.2 billion to $4,5 billion.
q4 adjusted earnings per share $1.01.
qtrly net sales rose 11 percent to $3.3 billion excluding our fine chemistry services business sold in june of 2021.
qtrly adjusted earnings per share $1.13.
q4 loss per share $4.0.
qtrly net sales increased 13 percent to $1.8 billion.
qtrly adjusted ebitda grew 13% to $871 million, surpassing upper end of guidance.
sees 2021 capital expenditures in range of $1.3 billion to $2.0 billion.
q4 sales $894 million versus refinitiv ibes estimate of $821.6 million.
sees fy 2021 adjusted ebitda margin of 27% to 29%.
q4 adjusted ebitda rose 12 percent to $1.2 billion excluding fcs.
sees 2025 lithium demand of about 1.5 million tons, up more than 30% from previous estimates.
compname reports fourth quarter and full year 2021 results and announces 3-year 2021 guidance.
expects new products to make up more than 10% of annual bromine revenues by 2025.
sees fy adjusted ebitda to grow between 35% and 55% versus 2021.
sees 2021 adjusted ebitda margin of 27% to 29%.
